Today's Medical News

Hematology & Oncology

Sacituzumab Govitecan Promising in Triple-Negative Breast Cancer

An antibody-drug conjugate, sacituzumab govitecan-hziy, shows promise in refractory metastatic triple-negative breast cancer, according to a study published in the Feb. 21 issue of the New England Journal of Medicine.

Surgery

Risk for Revision Surgery After Shoulder Replacement Varies

The lifetime risk for revision surgery after elective shoulder replacement surgery varies from 2.7 to 23.6 percent, according to a study published online Feb. 20 in The BMJ.

Conference Highlights

February 6 2019 - February 8 2019American Stroke Association, Feb. 6-8
December 4 2018 - December 8 2018CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 4-8
December 2 2018 - December 6 2018American Society of Health-System Pharmacists, Dec. 2-6
December 1 2018 - December 4 2018American Society of Hematology, Dec. 1-4
November 25 2018 - November 30 2018Radiological Society of North America, Nov. 25-30

Monthly Briefings